Tumor necrosis factor and interleukin 1 appearance in experimental gram-negative septic shock. The effects of plasma exchange with albumin and plasma infusion
- PMID: 2021343
- DOI: 10.1001/archsurg.1991.01410290067014
Tumor necrosis factor and interleukin 1 appearance in experimental gram-negative septic shock. The effects of plasma exchange with albumin and plasma infusion
Abstract
To study the effect of plasma removal vs plasma administration on the appearance of tumor necrosis factor (TNF) and interleukin 1 in septic shock, 24 anesthetized piglets were inoculated with live Escherichia coli. Plasma exchange with albumin was performed in one group. Fresh-frozen plasma was administered to a second group. A third group served as nontreated controls. Following plasma exchange, a reduction in both TNF and interleukin 1 levels occurred, whereas plasma infusion was followed by a decrease in TNF levels only. No significant differences were observed between the two treated groups with respect to survival or cardiovascular performance, with both being significantly enhanced compared with the controls. High levels of TNF and interleukin 1 correlated with depressed cardiovascular performance in the early phase of the shock. Our results confirm the important role of TNF and interleukin 1 as early mediators of septic shock. However, the benefit of reducing cytokine activity in later stages of septicemia seems to be dubious.
Similar articles
-
The effects of plasma and albumin infusion on organ function and sepsis markers in experimental gram-negative sepsis.Shock. 1994 Dec;2(6):402-7. doi: 10.1097/00024382-199412000-00003. Shock. 1994. PMID: 7743369
-
Repeated plasma therapy induces fatal shock in experimental septicemia.Circ Shock. 1993 Aug;40(4):268-75. Circ Shock. 1993. PMID: 8375029
-
Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.J Clin Invest. 1992 May;89(5):1551-7. doi: 10.1172/JCI115748. J Clin Invest. 1992. PMID: 1533231 Free PMC article.
-
Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.Prog Clin Biol Res. 1991;367:141-59. Prog Clin Biol Res. 1991. PMID: 1924424 Review.
-
Markers and mediators in enterogenic infectious-toxic shock.Curr Stud Hematol Blood Transfus. 1992;(59):163-203. doi: 10.1159/000429612. Curr Stud Hematol Blood Transfus. 1992. PMID: 1572213 Review. No abstract available.
Cited by
-
Downregulation of protein disulfide isomerase in sepsis and its role in tumor necrosis factor-alpha release.Crit Care. 2008;12(4):R100. doi: 10.1186/cc6977. Epub 2008 Aug 4. Crit Care. 2008. PMID: 18680601 Free PMC article.
-
Clinical review: extracorporeal blood purification in severe sepsis.Crit Care. 2003 Apr;7(2):139-45. doi: 10.1186/cc1889. Epub 2003 Feb 21. Crit Care. 2003. PMID: 12720560 Free PMC article. Review.
-
Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia.Clin Diagn Lab Immunol. 2003 Sep;10(5):813-20. doi: 10.1128/cdli.10.5.813-820.2003. Clin Diagn Lab Immunol. 2003. PMID: 12965910 Free PMC article.
-
Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster-randomized controlled trial.J Clin Apher. 2023 Feb;38(1):55-62. doi: 10.1002/jca.22027. Epub 2022 Oct 31. J Clin Apher. 2023. PMID: 36314372 Free PMC article. Clinical Trial.
-
Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure.Surg Today. 1995;25(7):585-90. doi: 10.1007/BF00311430. Surg Today. 1995. PMID: 7549268
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical